$BRC
BRADY CORP

2023 Q4 Form 10-Q Financial Statement

#000074659823000134 Filed on November 16, 2023

View on sec.gov

Income Statement

Concept 2023 Q4
Revenue $332.0M
YoY Change 2.92%
Cost Of Revenue $160.3M
YoY Change -4.21%
Gross Profit $171.7M
YoY Change 10.6%
Gross Profit Margin 51.73%
Selling, General & Admin $96.29M
YoY Change 7.05%
% of Gross Profit 56.07%
Research & Development $15.70M
YoY Change 12.7%
% of Gross Profit 9.14%
Depreciation & Amortization $7.466M
YoY Change -13.84%
% of Gross Profit 4.35%
Operating Expenses $112.0M
YoY Change 7.81%
Operating Profit $59.73M
YoY Change 16.24%
Interest Expense $766.0K
YoY Change -14.32%
% of Operating Profit 1.28%
Other Income/Expense, Net $438.0K
YoY Change -378.98%
Pretax Income $59.40M
YoY Change 18.01%
Income Tax $12.16M
% Of Pretax Income 20.47%
Net Earnings $47.24M
YoY Change 19.78%
Net Earnings / Revenue 14.23%
Basic Earnings Per Share
Diluted Earnings Per Share $0.95
COMMON SHARES
Basic Shares Outstanding 48.51M shares
Diluted Shares Outstanding 48.81M shares

Balance Sheet

Concept 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $175.4M
YoY Change 53.23%
Cash & Equivalents $175.4M
Short-Term Investments
Other Short-Term Assets $12.80M
YoY Change -0.79%
Inventory $166.9M
Prepaid Expenses
Receivables $180.0M
Other Receivables $0.00
Total Short-Term Assets $535.1M
YoY Change 6.32%
LONG-TERM ASSETS
Property, Plant & Equipment $143.8M
YoY Change 5.48%
Goodwill $583.7M
YoY Change 0.74%
Intangibles $58.77M
YoY Change -15.43%
Long-Term Investments
YoY Change
Other Assets $20.29M
YoY Change 2.19%
Total Long-Term Assets $848.3M
YoY Change 0.11%
TOTAL ASSETS
Total Short-Term Assets $535.1M
Total Long-Term Assets $848.3M
Total Assets $1.383B
YoY Change 2.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $79.51M
YoY Change -0.12%
Accrued Expenses $85.00M
YoY Change 0.34%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $251.7M
YoY Change 3.32%
LONG-TERM LIABILITIES
Long-Term Debt $52.30M
YoY Change -47.17%
Other Long-Term Liabilities $69.98M
YoY Change -13.32%
Total Long-Term Liabilities $69.98M
YoY Change -13.32%
TOTAL LIABILITIES
Total Short-Term Liabilities $251.7M
Total Long-Term Liabilities $69.98M
Total Liabilities $388.4M
YoY Change -11.5%
SHAREHOLDERS EQUITY
Retained Earnings $1.058B
YoY Change 14.92%
Common Stock $352.4M
YoY Change 1.84%
Preferred Stock
YoY Change
Treasury Stock (at cost) $300.5M
YoY Change 31.29%
Treasury Stock Shares
Shareholders Equity $995.0M
YoY Change
Total Liabilities & Shareholders Equity $1.383B
YoY Change 2.43%

Cashflow Statement

Concept 2023 Q4
OPERATING ACTIVITIES
Net Income $47.24M
YoY Change 19.78%
Depreciation, Depletion And Amortization $7.466M
YoY Change -13.84%
Cash From Operating Activities $62.27M
YoY Change 122.41%
INVESTING ACTIVITIES
Capital Expenditures $11.28M
YoY Change 192.13%
Acquisitions $0.00
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$11.28M
YoY Change 192.13%
FINANCING ACTIVITIES
Cash Dividend Paid $11.34M
YoY Change -0.33%
Common Stock Issuance & Retirement, Net $14.12M
YoY Change 16.99%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$21.49M
YoY Change 4.67%
NET CHANGE
Cash From Operating Activities $62.27M
Cash From Investing Activities -$11.28M
Cash From Financing Activities -$21.49M
Net Change In Cash $23.82M
YoY Change 5825.37%
FREE CASH FLOW
Cash From Operating Activities $62.27M
Capital Expenditures $11.28M
Free Cash Flow $50.99M
YoY Change 111.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
994992000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
911298000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
39441000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
39441000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-17437000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1155000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
66000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2958000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
911725000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
39441000 usd
CY2023Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7466000 usd
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8665000 usd
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
4163000 usd
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
2958000 usd
CY2023Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2225000 usd
CY2022Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1705000 usd
CY2023Q4 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1137000 usd
CY2022Q4 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
383000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2205000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
627000 usd
CY2023Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-6152000 usd
CY2022Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9582000 usd
CY2023Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1488000 usd
CY2022Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2563000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3725000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-14150000 usd
CY2023Q4 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
5757000 usd
CY2022Q4 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
5945000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
62273000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27999000 usd
CY2023Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11279000 usd
CY2022Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3861000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11279000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3861000 usd
CY2023Q4 us-gaap Payments Of Dividends
PaymentsOfDividends
11338000 usd
CY2022Q4 us-gaap Payments Of Dividends
PaymentsOfDividends
11376000 usd
CY2023Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2598000 usd
CY2022Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
349000 usd
CY2023Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2333000 usd
CY2022Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1504000 usd
CY2023Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
14121000 usd
CY2022Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
12070000 usd
CY2023Q4 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
38551000 usd
CY2022Q4 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
36000000 usd
CY2023Q4 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
36000000 usd
CY2022Q4 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
32000000 usd
CY2023Q4 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
1149000 usd
CY2022Q4 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
66000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21494000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-20535000 usd
CY2023Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-5680000 usd
CY2022Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3201000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
23820000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
402000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
151532000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
114069000 usd
CY2023Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
4065000 usd
CY2022Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
3780000 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48505000 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49868000 shares
CY2023Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
306000 shares
CY2022Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
222000 shares
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
97311000 usd
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
103350000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
26960000 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
26884000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
42645000 usd
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
46844000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
166916000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
177078000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
293708000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
292680000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
8133000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
8133000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
81885000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
23111000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
58774000 usd
CY2023Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
83225000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21129000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
62096000 usd
CY2023Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2355000 usd
CY2022Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3631000 usd
CY2023Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
4431000 usd
CY2022Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
4202000 usd
CY2023Q4 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1656000 usd
CY2022Q4 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
102000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-93061000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-21108000 usd
CY2023Q4 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-1114000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-115283000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-109077000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-16859000 usd
CY2022Q4 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-578000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-126514000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
-128000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
66000 usd
CY2023Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4163000 usd
CY2022Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2958000 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
425000 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
192000 usd
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48811000 shares
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2870000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2757000 usd
CY2023Q4 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
314000 usd
CY2022Q4 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
306000 usd
CY2023Q4 brc Remaining Performance Obligations Expected As Revenue During The Remainder Of The Current Fiscal Year
RemainingPerformanceObligationsExpectedAsRevenueDuringTheRemainderOfTheCurrentFiscalYear
0.31 rate
CY2023Q4 brc Remaining Performance Obligations Expected As Revenue Over The Next Full Fiscal Year
RemainingPerformanceObligationsExpectedAsRevenueOverTheNextFullFiscalYear
0.30 rate
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
331983000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
322569000 usd
CY2023Q4 brc Profit For Reportable Segments
ProfitForReportableSegments
66641000 usd
CY2022Q4 brc Profit For Reportable Segments
ProfitForReportableSegments
57903000 usd
CY2022Q4 brc Profit For Reportable Segments
ProfitForReportableSegments
57903000 usd
CY2023Q4 brc Administrative Costs
AdministrativeCosts
6911000 usd
CY2022Q4 brc Administrative Costs
AdministrativeCosts
6517000 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
438000 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-157000 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
766000 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
894000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
59402000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
50335000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1546783 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
42.05
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
52097 shares
CY2023Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
54.80
CY2023Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
174370 shares
CY2023Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
36.57
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
5433 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
48.82
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1419077 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
43.17
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
12727000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1195029 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
42.17
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y4M24D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
11851000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
47241000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
39441000 usd
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50090000 shares
CY2023Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
313787 shares
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
583533 shares
CY2023Q4 us-gaap Derivative Remaining Maturity1
DerivativeRemainingMaturity1
P18M
CY2023Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
68245000 usd
CY2023Q3 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
44464000 usd
CY2023Q4 us-gaap Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months
ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
2000 usd
CY2023Q3 us-gaap Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months
ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
1580000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
-294000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
893000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Investment Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
1508000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Investment Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
0 usd
CY2023Q4 us-gaap Foreign Currency Cash Flow Hedge Gain Loss Reclassified To Earnings Net
ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
1285000 usd
CY2022Q4 us-gaap Foreign Currency Cash Flow Hedge Gain Loss Reclassified To Earnings Net
ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
581000 usd
CY2023Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.205 rate
CY2022Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.216 rate
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0000746598-23-000134-index-headers.html Edgar Link pending
0000746598-23-000134-index.html Edgar Link pending
0000746598-23-000134.txt Edgar Link pending
0000746598-23-000134-xbrl.zip Edgar Link pending
brc-20231031.htm Edgar Link pending
brc-20231031.xsd Edgar Link pending
brc-20231031xex311.htm Edgar Link pending
brc-20231031xex312.htm Edgar Link pending
brc-20231031xex321.htm Edgar Link pending
brc-20231031xex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
brc-20231031_def.xml Edgar Link unprocessable
brc-20231031_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
brc-20231031_htm.xml Edgar Link completed
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
brc-20231031_cal.xml Edgar Link unprocessable
brc-20231031_lab.xml Edgar Link unprocessable